Literature DB >> 34175803

Multidimensional indices in the assessment of chronic obstructive pulmonary disease.

Alexandru Corlateanu1, Alexandra Plahotniuc2, Olga Corlateanu3, Victor Botnaru4, Andras Bikov5, Alexander G Mathioudakis5, Serghei Covantev6, Nikolaos Siafakas7.   

Abstract

Chronic obstructive pulmonary disease (COPD), a very common disease, is the third leading cause of death worldwide. Due to the significant heterogeneity of clinical phenotypes of COPD there is no single method suitable for predicting patients' health status and outcomes, and therefore multidimensional indices, assessing different components of the disease, were developed and are recommended for clinical practice by international guidelines. Several indices have been widely accepted: BODE and its modifications, ADO, DOSE, CODEX, COTE. They differ in their composition and aim, while they are more accurate and better validated in specific settings and populations. We review the characteristics, strengths and limitations of these indices, and we discuss their role in routine management of patients with COPD, as well as in specific clinical scenarios, such as resuscitation and ceiling of care, or decisions to offer more invasive treatments. This analysis may help clinicians to use those indexes in a more practical and appropriate way.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADO; BODE; CODEX; COPD; DOSE; Multidimensional indices

Mesh:

Year:  2021        PMID: 34175803     DOI: 10.1016/j.rmed.2021.106519

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  2 in total

Review 1.  Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?

Authors:  Jennifer M Wang; MeiLan K Han; Wassim W Labaki
Journal:  Curr Opin Pulm Med       Date:  2022-03-01       Impact factor: 3.155

Review 2.  Promoting Exercise Training Remotely.

Authors:  Stephanie A Robinson; Marilyn L Moy
Journal:  Life (Basel)       Date:  2022-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.